Recombinant Human Palmitoyltransferase ZDHHC17 (ZDHHC17)

What is the structural organization of ZDHHC17 and how does it relate to its function?

ZDHHC17 belongs to the DHHC family of S-acyltransferases, characterized by a conserved Asp-His-His-Cys (DHHC) motif essential for catalytic activity. The protein contains two main structural domains:

• An N-terminal ankyrin repeat domain (ANK17) that mediates substrate recognition and binding

• A catalytic DHHC domain containing the active site for the palmitoylation reaction

Crystal structure studies have revealed that the ankyrin repeat domain of ZDHHC17 forms specific interactions with substrates such as Snap25b . This domain is critical for substrate selectivity, as demonstrated by its interaction with the C-terminal linker-MH2 domains of Smad7 . Importantly, ZDHHC17 exhibits strict cytoplasmic localization, which is consistent with its role in mobilizing certain substrates like Smad7 to the cytoplasm .

The catalytic mechanism involves a two-step process: first, ZDHHC17 undergoes autopalmitoylation at the catalytic cysteine within the DHHC motif, and subsequently transfers the palmitoyl group to cysteine residues on target proteins . Mutations that disrupt this catalytic activity, such as the C467A or C467S substitutions, render the enzyme unable to effectively palmitoylate its substrates .

How does ZDHHC17 recognize and select its substrate proteins?

ZDHHC17 demonstrates selective substrate recognition primarily through its N-terminal ankyrin repeat domain. Several key findings illuminate this process:

• ZDHHC17 interacts with Smad7 predominantly through its N-terminal ankyrin repeats, binding to the C-terminal linker-MH2 domains of Smad7

• Unlike some other DHHC enzymes with broad substrate specificity, ZDHHC17 shows higher selectivity, as evidenced by its ability to palmitoylate Smad7 but not other Smad proteins (Smad2, Smad3, Smad4, Smad6) or TGF-β receptors

• Many ZDHHC17 substrates contain a zDHHC ankyrin-repeat binding motif (zDABM), though some substrates like Smad7 interact with ZDHHC17 through alternative binding interfaces

• Interestingly, the interaction between ZDHHC17 and Smad7 was found to be independent of the W130 residue that is essential for binding to other substrates with classical zDABM motifs

This selective substrate recognition is critical for understanding the specific cellular functions regulated by ZDHHC17-mediated palmitoylation.

What are the most effective methods to detect and quantify protein palmitoylation mediated by ZDHHC17?

Several complementary approaches have proven effective for detecting and quantifying ZDHHC17-mediated palmitoylation:

Acyl Resin-Assisted Capture (Acyl-RAC) Assay:

• Removes acyl groups from cysteine residues using hydroxylamine

• Directly conjugates freed cysteines to thiol-reactive resin

• Allows specific isolation and detection of S-acylated proteins

• Successfully used to detect Smad7 palmitoylation in experimental settings

Metabolic Labeling with Click Chemistry:

• Cells are labeled with alkynyl palmitic acid

• Click chemistry reaction links modified proteins to detectable tags

• Provides direct visualization of newly palmitoylated proteins

• Demonstrated significantly increased palmitoylation of Smad7 when ZDHHC17 was overexpressed

Site-Specific Mutagenesis:

• Systematic mutation of individual cysteine residues in target proteins

• Combined with either Acyl-RAC or metabolic labeling

• Identifies specific palmitoylation sites

• Revealed four cysteine residues in Smad7 (Cys202, Cys225, Cys415, and Cys417) as palmitoylation acceptor sites

Critical experimental controls should include:

• Treatment with palmitoylation inhibitor 2-bromopalmitate (2-BP)

• Comparison with catalytically inactive ZDHHC17 mutants (C467A/S)

• Hydroxylamine-free controls in Acyl-RAC experiments

What approaches can be used to investigate the functional consequences of ZDHHC17-mediated palmitoylation?

To determine the functional impacts of ZDHHC17-mediated palmitoylation, researchers can employ several approaches:

Protein Stability Analysis:

• Cycloheximide chase experiments to measure protein half-life

• Comparison of wild-type proteins versus palmitoylation-deficient mutants

• Has demonstrated that palmitoylation enhances Smad7 stability

Subcellular Localization Studies:

• Immunofluorescence microscopy of wild-type versus palmitoylation-deficient mutants

• Subcellular fractionation followed by western blotting

• Revealed that ZDHHC17-mediated palmitoylation promotes cytoplasmic localization of Smad7

Functional Reporter Assays:

• Pathway-specific reporter systems (e.g., CAGA-luciferase for TGF-β signaling)

• Comparison of wild-type versus palmitoylation-deficient proteins

• Showed that Smad7 C415/417A mutant had significantly reduced ability to inhibit TGF-β-dependent promoter activity

Protein-Protein Interaction Analysis:

• Co-immunoprecipitation experiments

• Proximity ligation assays

• Pull-down assays with recombinant proteins

• Demonstrated that ZDHHC17 interacts with Smad7 preferentially through its C-terminal domain

How does ZDHHC17-mediated palmitoylation regulate TGF-β signaling?

ZDHHC17 plays a crucial role in modulating TGF-β signaling through palmitoylation of the inhibitory protein Smad7:

Mechanism of Regulation:

• ZDHHC17 palmitoylates Smad7 at four cysteine residues: Cys202, Cys225, Cys415, and Cys417

• Palmitoylation at C415 and C417 in the C-terminal MH2 domain is particularly important for Smad7's function

• S-palmitoylation by ZDHHC17 promotes:

  • Translocation of Smad7 from the nucleus to the cytoplasm

  • Enhanced stability of the Smad7 protein

  • Increased inhibitory effect on TGF-β-induced Smad transcriptional responses

Experimental Evidence:

• CAGA-luciferase reporter assays showed that wild-type ZDHHC17 overexpression suppressed TGF-β-induced promoter activity

• The ZDHHC17ΔNAnk construct (with reduced ability to palmitoylate Smad7) showed less inhibitory effect on TGF-β signaling

• A Smad7 C415/417A mutant that cannot be palmitoylated at these sites showed significantly reduced ability to inhibit TGF-β-dependent promoter activity

This regulatory mechanism represents a novel post-translational modification that enhances the inhibitory effect of Smad7 against TGF-β signaling, adding another layer of control to this important signaling pathway .

What other substrates of ZDHHC17 have been identified and what are their functions?

ZDHHC17 has been found to palmitoylate several key substrates besides Smad7:

Neuronal Substrates:

• Snap25b: A SNARE protein essential for synaptic vesicle fusion and neurotransmitter release

• Huntingtin (HTT): The protein associated with Huntington's disease; ZDHHC17 palmitoylation affects its subcellular localization and potentially its neurotoxicity

Experimental Characterization:

• Crystal structure analysis has revealed specific interactions between the ankyrin repeat domain of ZDHHC17 (ANK17) and Snap25b

• Structure-guided mutagenesis identified key residues in ZDHHC17 that are critically important for interaction with both Snap25b and Huntingtin

• Unlike some broadly specific DHHC enzymes, ZDHHC17 shows substrate selectivity, as evidenced by its inability to palmitoylate other Smad proteins (Smad2, Smad3, Smad4, Smad6) or TGF-β receptors in the same pathway as Smad7

Understanding the diverse substrate profile of ZDHHC17 is essential for comprehending its wide-ranging roles in cellular processes, particularly in neuronal function and cell signaling pathways.

What is known about the structural basis of ZDHHC17-substrate recognition?

Recent structural and biochemical studies have provided significant insights into ZDHHC17-substrate recognition:

Key Structural Features:

Substrate Binding Determinants:

• Structure-guided mutagenesis has identified key residues in ZDHHC17 that are crucial for interaction with substrates

• For Smad7, ZDHHC17 preferentially binds to the C-terminal part containing the linker and MH2 domains

• Interestingly, the interaction between ZDHHC17 and Smad7 was found to be independent of W130, an essential residue for the binding of ZDHHC17 to other substrates

• This suggests that Smad7 does not contain a classical zDHHC ankyrin-repeat binding motif (zDABM)

These structural insights provide a foundation for understanding the molecular basis of ZDHHC17 substrate selectivity and may guide the development of specific modulators of ZDHHC17-substrate interactions.

How does ZDHHC17 compare to other DHHC family members in terms of substrate specificity?

ZDHHC17 exhibits distinctive characteristics compared to other DHHC family members:

Specificity Profile:

• ZDHHC17 is considered a high-selectivity/low-activity enzyme, requiring specific recognition of substrate proteins for successful S-acylation

• In contrast, enzymes like ZDHHC3 and ZDHHC7 are low-selectivity/high-activity isoforms that are active against numerous proteins without apparent specific recognition features

Substrate Recognition:

• ZDHHC17 primarily recognizes substrates through its N-terminal ankyrin repeat domain

• While many DHHC enzymes can palmitoylate multiple substrates, ZDHHC17 shows selectivity even within the same signaling pathway (e.g., palmitoylating Smad7 but not other Smad proteins)

Structural Relationships:

• ZDHHC17 shares structural similarities with ZDHHC13, another high-selectivity/low-activity enzyme

• ZDHHC17 is the human homolog of palmitoyl acyl-transferase dHIP14 which catalyzes Dad (Drosophila homolog of inhibitory Smad) palmitoylation in Drosophila

This distinctive substrate specificity profile makes ZDHHC17 particularly interesting for targeting specific cellular pathways without broadly affecting protein palmitoylation throughout the cell.

What are common challenges in expressing and purifying recombinant ZDHHC17 for in vitro studies?

Expressing and purifying functional recombinant ZDHHC17 presents several challenges:

Expression System Considerations:

• Mammalian expression systems (particularly HEK293T cells) have been successfully used for overexpression studies

• The transmembrane nature of ZDHHC17 complicates bacterial expression systems

• When designing expression constructs, N-terminal tags (FLAG, HA) are preferable, as C-terminal tags might interfere with the catalytic domain

Purification Challenges:

• Maintaining the native conformation of the transmembrane domains during purification

• Preserving catalytic activity throughout the purification process

• Preventing protein aggregation due to hydrophobic regions

Recommended Solutions:

• Use mild detergents during purification to solubilize the membrane-associated enzyme

• Include glycerol in buffers to enhance protein stability

• Validate purified protein function through autopalmitoylation assays

• For activity studies, consider reconstitution in liposomes or detergent micelles containing palmitoyl-CoA

• Monitor protein quality using size exclusion chromatography to ensure homogeneity

How can researchers differentiate between ZDHHC17-specific palmitoylation and modification by other DHHC enzymes?

Distinguishing ZDHHC17-specific palmitoylation from that catalyzed by other DHHC enzymes requires strategic experimental approaches:

Knockout/Knockdown Studies:

• Generate ZDHHC17-specific knockout or knockdown models

• Perform rescue experiments with wild-type versus catalytically inactive ZDHHC17 (C467A/S mutants)

• Compare palmitoylation patterns across multiple DHHC-family knockouts

Substrate Specificity Analysis:

• Examine palmitoylation of candidate substrates across all 23 DHHC family members

• For Smad7, studies have shown specificity for ZDHHC17-mediated palmitoylation compared to other proteins in the TGF-β pathway

Structural Analysis:

• Leverage the unique structural features of ZDHHC17, particularly its ankyrin repeat domain

• Investigate binding patterns that distinguish ZDHHC17 from other DHHC enzymes

• As shown with Smad7, substrate recognition by ZDHHC17 can involve specific domains and isn't always dependent on classical binding motifs

Quantitative Approaches:

• Compare palmitoylation efficiency across different DHHC enzymes

• Assess temporal dynamics of palmitoylation in synchronized cells

• Evaluate subcellular localization patterns of both enzyme and substrate